Back to browse

EXP002565

Paper

Molecular Parameters of siRNA–Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery (2013)

Peptide

R9-hLF

Sequence: Acetyl-RRRRRRRRRKCFQWQRNMRKVRGPPVSCIKR-NH2

RNA

siRNA

All experiment fields

Experiment Id EXP002565
Paper Molecular Parameters of siRNA–Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery
Peptide R9-hLF
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect no
Endosomal Escape Evidence
Peptide Concentration CPP concentration depended on molar ratio; optimized MR mostly 50, TP10 MR 100
Rna Concentration 50, 100, and 200 nM siGL3 in functional luciferase assays
Mixing Ratio Optimized molar ratio: MR 50 for all CPPs except TP10 MR 100
Formulation Format noncovalent CPP–siRNA nanocomplex
Formulation Components R9-hLF mixed noncovalently with siGL3; complexes characterized for size, zeta potential, serum stability, cell association, and luciferase knockdown
Size Nm 9.00
Zeta Mv 21.00
Model Scope in_vitro
Model Type in vitro reporter gene silencing / physicochemical CPP-siRNA nanocomplex study
Cell Lines Or Primary Cells SKNO-1 human leukemic cells stably expressing luciferase-IRES-EGFP
Animal Model
Administration Route in vitro transfection
Output Type luciferase reporter knockdown
Output Value ~19% luciferase knockdown at 200 nM siRNA; cell association present but low functional silencing
Output Units
Output Notes Despite high positive charge and siRNA complexation, R9-hLF showed minimal functional luciferase knockdown.
Toxicity Notes WST-1 showed no significant metabolic toxicity at 50–200 nM siRNA; LDH membrane toxicity was peptide-dependent and generally increased at higher complex concentrations.
Curation Notes